REFERENCES
- Trad S, Bodaghi B, Saadoun D. Update on immunological test (Quantiferon-TB gold) contribution in the management of tuberculosis-related ocular inflammation. Ocul Immunol Inflamm. July 2017:1–8. doi:10.1080/09273948.2017.1332232.
- Weyer K, Gilpin C, Mirzayev F, Van Gemert W, World Health Organization. Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement. 2011. http://www.ncbi.nlm.nih.gov/books/NBK310677/. Accessed August 9, 2017.
- Ang M, Htoon HM, Chee SP. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology. 2009;116:1391–1396.
- Ang M, Wong W, Ngan CC, Chee SP. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye (Lond). 2012;26:658–665.
- La Distia Nora R, Van Velthoven ME, Ten Dam-Van Loon NH, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;157:754–761.
- Jakob E, Max R, Zimmermann S, et al. Three years of experience with QuantiFERONTB gold testing in patients with uveitis. Ocul Immunol Inflamm. 2014;22:478–484.